PSMB6
Introduction
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">PSMB6</th>
</tr>
<tr>
<td class="label">Attribute</td>
<td>Value</td>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>PSMB6</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Proteasome Subunit Beta 6</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>17p13.1</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>5699</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>N/A</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000104613</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>P28074</td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>204 amino acids</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~25 kDa</td>
</tr>
<tr>
<td class="label">Subunit</td>
<td>Activity</td>
</tr>
<tr>
<td class="label">PSMB6 (β6)</td>
<td>Caspase-like (post-acidic)</td>
</tr>
<tr>
<td class="label">PSMB2 (β2)</td>
<td>Trypsin-like</td>
</tr>
<tr>
<td class="label">PSMB5 (β5)</td>
<td>Chymotrypsin-like</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
Psmb6 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
...PSMB6
Introduction
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">PSMB6</th>
</tr>
<tr>
<td class="label">Attribute</td>
<td>Value</td>
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>PSMB6</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Proteasome Subunit Beta 6</td>
</tr>
<tr>
<td class="label">Chromosomal Location</td>
<td>17p13.1</td>
</tr>
<tr>
<td class="label">NCBI Gene ID</td>
<td>5699</td>
</tr>
<tr>
<td class="label">OMIM</td>
<td>N/A</td>
</tr>
<tr>
<td class="label">Ensembl ID</td>
<td>ENSG00000104613</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td>P28074</td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>204 amino acids</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~25 kDa</td>
</tr>
<tr>
<td class="label">Subunit</td>
<td>Activity</td>
</tr>
<tr>
<td class="label">PSMB6 (β6)</td>
<td>Caspase-like (post-acidic)</td>
</tr>
<tr>
<td class="label">PSMB2 (β2)</td>
<td>Trypsin-like</td>
</tr>
<tr>
<td class="label">PSMB5 (β5)</td>
<td>Chymotrypsin-like</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>
Psmb6 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
PSMB6 (Proteasome Subunit Beta 6) encodes the β6 catalytic subunit of the 20S proteasome core particle. This subunit provides the proteasome's caspase-like (or post-acidic) proteolytic activity, cleaving peptides after acidic residues. PSMB6 is essential for proper proteasome function and plays a critical role in protein homeostasis throughout the central nervous system. [@ubiquitinproteasome2019]
The proteasome is a key component of the [ubiquitin-proteasome system](/mechanisms/ubiquitin-proteasome-system) (UPS), which is responsible for degrading misfolded, oxidized, and regulatory proteins. In [neurons](/entities/neurons), where protein turnover is carefully regulated to maintain synaptic function and prevent aggregation, proteasome activity is particularly crucial. [@structure2019]
Protein Structure
PSMB6 is a catalytic β-subunit belonging to the Ntn-hydrolase family. The protein contains an N-terminal threonine residue (Thr1) that serves as the active site nucleophile for proteolysis.
Key Structural Features
- N-terminal Thr active site: The catalytic threonine is exposed upon proteasome assembly
- S1 pocket: Substrate binding pocket that recognizes basic residues
- Catalytic core: Forms part of the proteasome's proteolytic chamber (β6 ring position)
- Interaction interfaces: Contacts adjacent α and β subunits for proper assembly
Function in Protein Degradation
Proteasome Catalytic Activity
The 20S proteasome contains three distinct catalytic subunits with different substrate specificities:
PSMB6's caspase-like activity is essential for:
- Degradation of regulatory proteins
- Processing of transcription factors
- Clearance of oxidized proteins
- MHC class I antigen presentation
Role in Neuronal Protein Homeostasis
In neurons, the proteasome system is critical for:
- Synaptic protein turnover
- Axon guidance molecule degradation
- Neurotransmitter receptor regulation
- Clearance of misfolded proteins
Expression Pattern
Brain Expression
PSMB6 is ubiquitously expressed throughout the brain with high levels in:
- Cerebral [cortex](/brain-regions/cortex): Pyramidal neurons and interneurons
- [Hippocampus](/brain-regions/hippocampus): CA1-CA3 regions and dentate gyrus
- Cerebellum: Purkinje cells and granule cells
- Substantia nigra: Dopaminergic neurons
- Spinal cord: Motor neurons
Cellular Localization
- Cytoplasmic: Majority of proteasomes are cytosolic
- Nuclear: Nuclear proteasomes regulate transcription factors
- Synaptic: Local proteasome activity at synapses regulates synaptic plasticity
Role in Neurodegenerative Diseases
Alzheimer's Disease
Proteasome activity is significantly reduced in AD brain tissue, contributing to:
- [Amyloid-beta](/proteins/amyloid-beta) accumulation due to impaired clearance
- [Tau](/proteins/tau) protein aggregation
- Synaptic protein dysfunction
- Neuronal death
Research has shown that PSMB6 expression and activity are altered in AD:
- [Proteasome subunit expression is dysregulated in AD](https://doi.org/10.1007/s00401-019-02034-8) (Acta Neuropathol, 2019)
- Post-translational modifications of PSMB6 may impair catalytic activity
- Oxidative stress in AD affects proteasome function
Parkinson's Disease
The [ubiquitin-proteasome system](/mechanisms/ubiquitin-proteasome-system) is central to PD pathogenesis:
- [Alpha-synuclein](/proteins/alpha-synuclein) clearance relies on proteasomal degradation
- Mutations in proteasome-related genes increase PD risk
- Proteasome impairment contributes to Lewy body formation
Amyotrophic Lateral Sclerosis (ALS)
- Proteasome dysfunction is observed in ALS motor neurons
- [TDP-43](/mechanisms/tdp-43-proteinopathy) aggregation overwhelms proteasome capacity
- Proteasome activators are being investigated as therapeutic targets
Therapeutic Implications
Proteasome-Targeted Therapies
While PSMB6 itself is not a direct drug target, understanding its function informs:
- Proteasome modulators: Compounds that enhance or restore proteasome activity
- Protein aggregation inhibitors: Agents that reduce toxic protein load
- Gene therapy approaches: Viral vectors expressing proteasome subunits
Research Directions
- Developing brain-penetrant proteasome activators
- Understanding post-translational modifications of PSMB6
- Investigating proteasome-stabilizing compounds
Animal Models
- Knockout mice: PSMB6 deletion is embryonic lethal, highlighting essential function
- Conditional knockouts: Neuron-specific deletion shows accumulation of ubiquitinated proteins
- Transgenic models: Overexpression studies reveal protective effects against proteotoxic stress
Cross-Links
- [26S Proteasome](/proteins/26s-proteasome)
- [Ubiquitin-Proteasome System](/mechanisms/ubiquitin-proteasome-system)
- [Protein Aggregation](/mechanisms/protein-aggregation)
- [Alzheimer's Disease](/diseases/alzheimers-disease)
- [Parkinson's Disease](/diseases/parkinsons-disease)
See Also
- [20S Proteasome](/proteins/20s-proteasome) - The proteolytic core complex
- [PSMB2](/genes/psmb2) - Trypsin-like subunit
- [PSMB5](/genes/psmb5) - Chymotrypsin-like subunit
- [Ubiquitin-Proteasome System](/mechanisms/ubiquitin-proteasome-system) - Protein degradation pathway
- [Protein Homeostasis](/mechanisms/protein-homeostasis) - Cellular protein balance
External Links
- [NCBI Gene: PSMB6](https://www.ncbi.nlm.nih.gov/gene/5692)
- [UniProt: P60981](https://www.uniprot.org/uniprotkb/P60981)
- [Ensembl: ENSG00000100982](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000100982)
- [GeneCards: PSMB6](https://www.genecards.org/cgi-bin/carddisp.pl?gene=PSMB6)
Background
The study of Psmb6 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
References
[Unknown, Proteasome subunit alterations in neurodegenerative disease brains (2019)](https://doi.org/10.1007/s00401-019-02034-8)
[Unknown, The ubiquitin-proteasome system in Alzheimer's disease pathogenesis (2019)](https://doi.org/10.1007/s00401-019-02067-5)
[Unknown, Structure of the human 20S proteasome (2019)](https://doi.org/10.1016/j.tibs.2019.06.005)
[Unknown, Proteasome dysfunction in Parkinson's disease (2020)](https://doi.org/10.1016/j.neurobiolaging.2020.02.019)
[Unknown, Caspase-like activity of the proteasome (2018)](https://doi.org/10.1016/j.jmb.2018.09.013)
[Unknown, Neuronal proteostasis and neurodegenerative disease (2020)](https://doi.org/10.1016/j.neuron.2020.09.015)
[Unknown, Oxidative stress and proteasome function (2019)](https://doi.org/10.1016/j.freeradbiomed.2019.11.032)
[Unknown, Therapeutic targeting of the proteasome in neurodegeneration (2021)](https://doi.org/10.1038/s41582-021-00512-8)